Flotetuzumab | m-entrepreneurship.com

Product Name :
Flotetuzumab

Search keywords :
Flotetuzumab

drugId :
null

Target Vo:
T cell surface glycoprotein CD3

Target Vo Short Name :
CD3

Moa_Name:
Interleukin-3 receptor subunit alpha inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Macrogenics Inc

Active Company_Name :
Laboratoires Servier

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:
Leukemia, Biphenotypic, Acute

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
EpCAM Antibody (YA772)
Moesin Antibody
Ezrin Antibody (YA767): Ezrin Antibody (YA767) is a non-conjugated and Mouse origined monoclonal antibody about 69 kDa, targeting to Ezrin (2C12). It can be used for WB assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts